Preferred Label : HER2-Positive Breast Carcinoma;

NCIt synonyms : ERBB2 Overexpressing Subtype of Invasive Breast Carcinoma; ERBB2 Overexpressing Subtype of Breast Carcinoma; HER2 Overexpressing Breast Carcinoma; HER2 Overexpressing Subtype of Breast Carcinoma; HER2 Positive Breast Cancer; HER2 Positive Breast Carcinoma;

NCIt definition : A biologic subset of breast carcinoma defined by high expression of HER2, GRB7, and TRAP100, and by lack of expression of estrogen receptor (ER).;

Neoplastic status : Malignant;

Details


Main resources

You can consult :


https://pgtmsite.files.wordpress.com/2024/01/trastuzumab-emtansine_position-preliminaire_final-27oct2014.pdf
2014
Canada
drug information
Metastatic Malignant Neoplasm in the Breast
trastuzumab
neoplasm, malignant
HER2/Neu Positive
HER2-Positive Breast Carcinoma
breast neoplasms
trastuzumab emtansine
Trastuzumab Emtansine
HER-2 positive breast cancer
Ado-Trastuzumab Emtansine
Breast Cancer Therapeutic Procedure
breast cancer

---
Nous contacter.
04/05/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.